Menu

Crystalys makes its debut with $205M to advance next-gen gout drug

Article |

RadiantIST81t 2mo ago
Crystalys makes its debut with $205M to advance next-gen gout drug

Crystalys Therapeutics emerged from stealth Tuesday with $205 million in series A financing to advance dotinurad — an oral gout therapy...

Comments (0)

Newest

No comments yet.